There was a highly significant protective effect on subjects 60–75 years (HR 0.65 and 0.67 for unadjusted and adjusted), while no effect on those above 75.
← all excerpts
Prescription database analyses indicates that the asthma medicine montelukast might protect against dementia: a hypothesis to be verified.
1
—
—